Seltene Ursache einer Anämie bei einer nierentransplantierten Patientin
暂无分享,去创建一个
[1] N. Enomoto,et al. Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins. , 2005, Gastroenterology.
[2] C. Tschöpe,et al. High Prevalence of Cardiac Parvovirus B19 Infection in Patients With Isolated Left Ventricular Diastolic Dysfunction , 2005, Circulation.
[3] G. Sunder-Plassmann,et al. A rare cause of anemia due to intestinal tuberculosis in a renal transplant recipient. , 2004, Clinical nephrology.
[4] P. Macpherson,et al. Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. , 2004, Blood.
[5] G. Wolf,et al. Angiotensin II Induces Hypoxia-Inducible Factor-1α in PC 12 Cells through a Posttranscriptional Mechanism: Role of AT2 Receptors , 2004, American Journal of Nephrology.
[6] I. Helal,et al. Parvovirus B19-related Anaemia After Renal Transplantation , 2004, Scandinavian journal of infectious diseases.
[7] M. Schoppet,et al. Parvovirus B19 genome in endomyocardial biopsy specimen. , 2004, Circulation.
[8] A. Nosari,et al. Bone marrow hypoplasia complicating tacrolimus (FK506) therapy , 2004, International journal of hematology.
[9] R. Kusec,et al. Angiotensin I‐converting enzyme is expressed by erythropoietic cells of normal and myeloproliferative bone marrow , 2003, British journal of haematology.
[10] K. Shimotohno,et al. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes , 2003, Hepatology.
[11] J. Bosmans,et al. Four cases of red blood cell aplasia in association with the use of mycophenolate mofetil in renal transplant patients. , 2003, Clinical nephrology.
[12] D. Abramowicz,et al. Prevalence and Management of Anemia in Renal Transplant Recipients: A European Survey , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] R. Gohh,et al. Donor‐transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction , 2002, Transplant infectious disease : an official journal of the Transplantation Society.
[14] B. Altun,et al. Pure Red Cell Aplasia Preceding Malignant Lymphoma in a Renal Transplant Patient , 2002, Nephron.
[15] S. Choi,et al. A Case of Persistent Anemia in a Renal Transplant Recipient: Association with Parvovirus B19 Infection , 2002, Scandinavian journal of infectious diseases.
[16] B. Rogachev,et al. Severe Coombs’-Negative Autoimmune Hemolytic Anemia in a Kidney Transplant Patient , 2001, American Journal of Nephrology.
[17] E. Gertner,et al. Antibodies to beta 2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection. , 2001, The Journal of rheumatology.
[18] E. Kraus,et al. Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature , 2000, Clinical transplantation.
[19] F. Zacchello,et al. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.
[20] C. Szeto,et al. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] P. Mannucci,et al. The transfusion-associated transmission of parvovirus B19. , 1999, Transfusion medicine reviews.
[22] J. Ménard,et al. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. , 1996, The Journal of clinical investigation.
[23] Risks associated with human parvovirus B19 infection. , 1989, MMWR. Morbidity and mortality weekly report.
[24] J. Lefrère,et al. [Parvovirus B 19]. , 1986, Presse medicale.
[25] A. Woolf,et al. HUMAN PARVOVIRUS ARTHROPATHY , 1985, The Lancet.